The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IASLC TTLC 2024 | Characterization and diagnosis of NUT carcinoma
Jia Luo, MD, Dana-Farber Cancer Institute, Boston, MA, provides an overview of the disease biology and diagnostic techniques for NUT carcinoma, which occurs in approximately 1,400 patients in the US every year. NUT carcinoma is often underdiagnosed, due it being a fusion oncogene and requiring RNA-based sequencing. The lack of a defined histology additionally makes diagnosis difficult and NUT IHC/FISH tests are available for clinicians. This interview took place at 2024 Targeted Therapies of Lung Cancer Meeting (TTLC 2024) in Santa Monica, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
